Angelo Cabal
Impact in
- Oncology top 2%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 10
- COVID-19 and healthcare impacts 9
- Cancer Immunotherapy and Biomarkers 1
-
- COVID-19 Clinical Research Studies 5
- Co-authors
- Ilan N. Wapinski (1 shared paper)Byoung‐Mo Koo (1 shared paper)Horia Todor (1 shared paper)Harvey H. Kimsey (1 shared paper)Anna‐Barbara Hachmann (1 shared paper)Jason M. Peters (1 shared paper)George Kritikos (1 shared paper)Athanasios Typas (1 shared paper)
- Journals
- JAMA Network Open (3 papers)Clinical Genitourinary Cancer (3 papers)JAMA Oncology (2 papers)Cancer Medicine (2 papers)The Lancet (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Angelo Cabal
18 papers receiving 2.4k citations
Angelo Cabal's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 1.2k
- Infectious Diseases 852
- Genetics 295
- Health 55
- Modeling and Simulation 24
Countries citing papers authored by Angelo Cabal
This map shows the geographic impact of Angelo Cabal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Cabal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Cabal more than expected).
Fields of papers citing papers by Angelo Cabal
This network shows the impact of papers produced by Angelo Cabal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Cabal. The network helps show where Angelo Cabal may publish in the future.
Co-authors
The 25 scholars most cited alongside Angelo Cabal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Hit paper breakdown → | 2020 | 1348 |
| 2 | Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis Hit paper breakdown → | 2017 | 467 |
| 3 | 2021 | 240 | |
| 4 | 2021 | 156 | |
| 5 | 2022 | 47 | |
| 6 | 2022 | 32 | |
| 7 | 2021 | 30 | |
| 8 | 2014 | 28 | |
| 9 | 2020 | 26 | |
| 10 | 2021 | 25 | |
| 11 | 2022 | 19 | |
| 12 | 2022 | 18 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2024 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2021 | 2 |
About Angelo Cabal
Angelo Cabal is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Structural Biology and Geriatrics and Gerontology, having authored 18 papers that have together received 2.5k indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (9 papers), COVID-19 Clinical Research Studies (5 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Immunotherapy and Biomarkers (1 paper), Cancer Genomics and Diagnostics (1 paper), Microbial Metabolic Engineering and Bioproduction (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Bacterial Genetics and Biotechnology (1 paper). The work is most often cited by research in Oncology (1.2k citations), Infectious Diseases (852 citations), Genetics (295 citations), Health (55 citations) and Modeling and Simulation (24 citations). Angelo Cabal has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Ilan N. Wapinski, Byoung‐Mo Koo, Horia Todor, Harvey H. Kimsey, Anna‐Barbara Hachmann, Jason M. Peters, George Kritikos, Athanasios Typas, David Z. Rudner and Karen N. Allen. Their work appears in journals such as JAMA Network Open, Clinical Genitourinary Cancer, JAMA Oncology, Cancer Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.